Sister company of Google wants to bid on managed care

Verily, the healthcare unit of Google’s parent company Alphabet, is planning a move into the health insurance market by joining with existing insurers for bids on care management and population health contracts.

According to CNBC, the division formerly known as Google Life Sciences has been in talks with insurers to bid for managed care contracts offered by state governments or employers. It previously decided against a very similar proposal to work with Oscar Health to bid for Rhode Island’s Medicaid managed care business.

The downside risk involved with managed care hasn’t stopped payers, particularly state Medicaid programs, from increasingly turning towards the model for its lower-income population. While Verily’s plan may make use of these data analytics capabilities, the healthcare space requires a different approach to risk which may be challenging for technology companies.

“Taking on (health) risk is a different order of magnitude of complexity than what we see in other industries,” said Robert Mittendorff, a venture capitalist with Norwest Venture Partners. “It requires the right team, with the right resources and the right focus.”

Read more at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.